Kenyan politician and former Cabinet Secretary for Defence
The FDA has approved daraxonrasib (Rasonque), a once-daily pill from Revolution Medicines, for adults with metastatic pancreatic cancer who have received prior therapy or cannot take combination chemotherapy. A 500‑patient trial has shown median survival of 13.2 months versus 6.7 months for chemotherapy; a 30‑day supply will cost about $39,800 and expanded access has already treated thousands.
Kenya has confirmed its first imported case of Bundibugyo Ebola after a Kenyan national who fell ill in the Democratic Republic of Congo travelled by road through Uganda and flew to Nairobi on Oct. 3. The patient tested positive, died on Oct. 5 and was buried under safe-burial protocols; Kenyan authorities have identified 28 contacts and are tracing flight passengers and crew.